ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Cenote Pharma Limited

Cenote Pharma Limited is an active company incorporated on 10 December 2015 with the registered office located in Newbury, Berkshire. Cenote Pharma Limited was registered 9 years ago.
Status
Active
Active since 7 years ago
Company No
09910964
Private limited company
Age
9 years
Incorporated 10 December 2015
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 29 November 2024 (11 months ago)
Next confirmation dated 29 November 2025
Due by 13 December 2025 (1 month remaining)
Last change occurred 11 months ago
Accounts
Submitted
For period 7 Mar31 Dec 2024 (9 months)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Elizabeth House
13-19 London Road
Newbury
Berkshire
RG14 1JL
United Kingdom
Same address for the past 4 years
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in Apr 1970
Director • British • Lives in England • Born in Feb 1986
Director • British • Lives in England • Born in Aug 1976
Aspire Pharma Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Morningside Pharmaceuticals Limited
Richard Michael Condon, Gary David Buckley, and 1 more are mutual people.
Active
Morningside Healthcare Limited
Richard Michael Condon, Gary David Buckley, and 1 more are mutual people.
Active
Aspire Pharma Limited
Richard Michael Condon, Gary David Buckley, and 1 more are mutual people.
Active
Charlwood Pharma Limited
Richard Michael Condon, Gary David Buckley, and 1 more are mutual people.
Active
Alvedius Ltd
Richard Michael Condon, Gary David Buckley, and 1 more are mutual people.
Active
Saint-Germain Pharma Ltd
Richard Michael Condon, Gary David Buckley, and 1 more are mutual people.
Active
Aitma Limited
Richard Michael Condon, Gary David Buckley, and 1 more are mutual people.
Active
APHL 2 Limited
Richard Michael Condon, Gary David Buckley, and 1 more are mutual people.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Dec 2024
For period 2 Mar31 Dec 2024
Traded for 10 months
Cash in Bank
Unreported
Decreased by £63.34K (-100%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Decreased by 3 (-100%)
Total Assets
£4.5K
Decreased by £756.07K (-99%)
Total Liabilities
£0
Decreased by £541.5K (-100%)
Net Assets
£4.5K
Decreased by £214.57K (-98%)
Debt Ratio (%)
0%
Decreased by 71.2% (-100%)
Latest Activity
Small Accounts Submitted
4 Months Ago on 4 Jul 2025
Accounting Period Shortened
6 Months Ago on 14 Apr 2025
Confirmation Submitted
11 Months Ago on 29 Nov 2024
Full Accounts Submitted
1 Year 2 Months Ago on 29 Aug 2024
Accounting Period Shortened
1 Year 5 Months Ago on 5 Jun 2024
Full Accounts Submitted
1 Year 5 Months Ago on 4 Jun 2024
Keith Williams Resigned
1 Year 8 Months Ago on 7 Mar 2024
Paul Ranson Resigned
1 Year 8 Months Ago on 7 Mar 2024
Mr Jonathan Charles May Appointed
1 Year 8 Months Ago on 7 Mar 2024
Keith Williams (PSC) Resigned
1 Year 8 Months Ago on 7 Mar 2024
Get Credit Report
Discover Cenote Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Accounts for a small company made up to 31 December 2024
Submitted on 4 Jul 2025
Previous accounting period shortened from 6 March 2025 to 31 December 2024
Submitted on 14 Apr 2025
Confirmation statement made on 29 November 2024 with updates
Submitted on 29 Nov 2024
Total exemption full accounts made up to 6 March 2024
Submitted on 29 Aug 2024
Previous accounting period shortened from 30 October 2024 to 6 March 2024
Submitted on 5 Jun 2024
Total exemption full accounts made up to 30 October 2023
Submitted on 4 Jun 2024
Cessation of Michael Stuart Close as a person with significant control on 7 March 2024
Submitted on 11 Mar 2024
Termination of appointment of Michael Stuart Close as a director on 7 March 2024
Submitted on 11 Mar 2024
Notification of Aspire Pharma Limited as a person with significant control on 7 March 2024
Submitted on 11 Mar 2024
Cessation of Paul Ranson as a person with significant control on 7 March 2024
Submitted on 11 Mar 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year